Navigation Links
Chair of U.S. Preventive Services Task Force Pledges to Recommend Re-evaluation of Recent Glaucoma Findings
Date:10/24/2007

Hon. Louis Sullivan, M.D., Former Secretary of HHS, Senator Norm Coleman, Deputy HHS Secretary Tevi Troy, Hon. Mark McClellan, M.D., Ph.D., and members of the patient and medical community participate in a conference to consider the scientific evidence countering the United States Preventive Services Task Force report dismissing the vital role of Glaucoma Screening

ARLINGTON, Va., Oct. 24 /PRNewswire-USNewswire/ -- The Potomac Institute for Policy Studies and the Glaucoma Foundation convened a daylong conference at the National Press Club to examine the recent United States Preventive Services Task Force (USPSTF) determination that there is insufficient scientific evidence to support the practice of screening for glaucoma. Participants called for transparency and accountability in the USPSTF's process for formulating its recommendations in the future.

The conference was addressed by Dr. Louis Sullivan, the Former Secretary of the Department of Health and Human Services (HHS); Dr. Tevi Troy, the current Deputy Secretary of HHS; Dr. Mark McClellan, former Commissioner of FDA and former Medicare Administrator; and Senator Norm Coleman (MN), in addition to glaucoma patients and advocates, two medical school deans, scientific experts, and representatives of Medicare, the Veterans Health Administration (VA), the National Commission for Quality Assurance (NCQA), and the former Surgeon General of the U.S. Navy.

The conference was convened because the USPSTF had previously declined to consider public comment presenting new information, and the speakers highlighted the urgent need for review of the evidence before patients might be further harmed. As Dr. Sullivan, the honorary conference chair, called for greater openness and transparency in the USPSTF policy process in his opening remarks, saying, " ... we're holding the hearing that should have been held, here in the public eye." Dr. Sullivan went on to say,

"How could it be that in the fa
'/>"/>

SOURCE The Potomac Institute for Policy Studies
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine news :

1. New Chair Invented To Relieve Backache
2. Wood Appointed As the First Chair of SAADAT
3. ISB To Establish Research Chair On Real Estate And Urban Studies
4. Disabled Children Claims For NHS Funded Wheelchairs
5. Robot Wheelchair Maybe Helpful for Wheelchair-dependent Patients
6. Wheelchair Raises A Furore
7. Lose stomach for Life....Preventive removal of stomach saves the risk of cancer
8. Research on causes for falling helps develop preventive strategies
9. Preventive Therapies Found to be More Effective in Managing Migraines
10. Poor Preventive Measures Taken By Diabetics
11. Diabetics Should Adopt Better Preventive Measures

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/26/2009)...unications announces a highly effective and unconv...ggling to make an economic recovery. , ...rs is the type of challenge that could send ailing... Dr. David Benton, business growth expert and auth...dash; The Rfactor Intensive . “Fear is on...
(Date:11/25/2009)...ire/--TheBartleHallConventionCenterwilltemporarily...enKansasCityhoststhelatestinaseriesofmassivefreecl...thasthepotentialtobethebiggestoneyet,becauseitwill...ysinsteadofoveraweekend,"SheriWood,executivedirect...NationalAssociationofFreeClinics(NAFC). ,, Atpr...
(Date:11/25/2009)...ntinelleMedicalInc.,aleadingmanufacturerofbreastMR...teofnewleadingedgeclinicalapplicationsonitsAegis(T...ogicalSocietyofNorthAmerica(RSNA)annualmeetinginCh...ationsleveragetheuniquehighqualityimagesgeneratedb...ultipleimagingmodalitiesformulti-parametricassessm...
(Date:11/25/2009)...USNewswire/--TheBlackAIDSInstituterecentlyheldBoar...for2010. ,, ThenewBoardMembersareahighlydiverse...nance,governmenthealthprograms,editorial,andbusine...ofpersonalbackgroundsincludingbothheterosexualandg...representingmultipleagegroups. ,, (Photo: http:...
(Date:11/25/2009)...ancer who were treated with cisplatin-based chemot...rological side effects and Raynaud-like phenomena,...according to a new study published online November...te . , Marianne Brydy, M.D., of the Department o...en, Norway, and colleagues conducted a cross-secti...
Breaking Medicine News(10 mins):Health News:Pharmacist Injects Cure for Ailing Businesses 2Health News:Kansas City Prepares for Largest Free Health Clinic 2Health News:Sentinelle Medical Launches Aegis Suite of Oncology 4D Visualization Software with PureWeb(TM) Technology 2Health News:Sentinelle Medical Launches Aegis Suite of Oncology 4D Visualization Software with PureWeb(TM) Technology 3Health News:Black AIDS Institute Announces 2010 Board Election Results 2
...ology says that it is possible to reduce high bloo... Scientists, in an attempt to study the effects of...lar responses, had found out the result from the r...lectro-puncture. Acupuncture is one of the t...
... laproscopic surgery, may require the use of a pul...ays a study published in the new issue of Archives...hat has a genetic component and often gets magnifi...ne of the most common procedures to control morbid...
... inner ear may restore partial hearing ability of ...n Nature Medicine. Scientists are of the ... regulatory gene called Atoh1 can be used to encou...cells of the inner ear are encouraged to change th...
...lic Health had found out that the intake of vitami...erosis (MS) in women. The study said that women wh...e of developing MS than the ones who did not take ...odern day treatment may slow the course of develop...
...like keratitis by wearing the latest silicone hydr...rnal// of Ophthalmology. Scientists showed th...ar or extended wear contact lenses have varied res...tudy and had used a clinical severity matrix to di...
...cer patients and people without liver cancer found...developing liver cancer compared to the general po...nt, such as demographics and major risk factors fo...cancer, may be boosting the risk even further. ...
Other Medicine News:
(Date:11/25/2009)...Newswire-FirstCall/--NuVasive,Inc.(Nasdaq: NUVA ),...rminimallydisruptivesurgicaltreatmentsforthespine,...y,November30,2009,at5:30p.m.ET/2:30p.m.PT.Theconfe...sementfortheCompany,sproductsandwillincludecomment...ssion.Thedial-innumbersare1-877-407-4018fordomesti...
(Date:11/25/2009)...dSYDNEY,Nov.25/PRNewswire-FirstCall/--HeartWareInt...ovatorandprovideroflessinvasive,miniaturizedcircul...tofadvancedheartfailure,todayannouncedthatitissche...perJaffrayHealthCareConferenceat8:00amESTonWednesd...YorkPalaceHotel,December1-2. ,, Alivewebcastoft...
(Date:11/24/2009)...4/PRNewswire-FirstCall/--QuestDiagnosticsIncorpora...tictesting,informationandservices,announcedthatiti...careConferenceinNewYorkCity.Thepresentationissched...me. ,, Duringtheconference,thecompanywillreaffi...peratingincometoexceed18%ofrevenues,anddilutedearn...
Breaking Medicine Technology:NuVasive Announces Conference Call and Webcast Regarding Reimbursement 2NuVasive Announces Conference Call and Webcast Regarding Reimbursement 3Quest Diagnostics To Speak At The 21st Annual Piper Jaffray Healthcare Conference 2Ascenta Therapeutics Receives Clearance to Initiate Clinical Trials With AT 406 56738 1Ascenta Therapeutics Receives Clearance to Initiate Clinical Trials With AT 406 56738 2Amicus Therapeutics to Present at the Morgan Stanley Global Healthcare Unplugged Conference on September 14 2009 56735 1NBTY To Web Cast Presentation at CL King Best Ideas Conference 3B Announces Preliminary Unaudited Net Sales Results For August 2009 56732 1NBTY To Web Cast Presentation at CL King Best Ideas Conference 3B Announces Preliminary Unaudited Net Sales Results For August 2009 56732 2NBTY To Web Cast Presentation at CL King Best Ideas Conference 3B Announces Preliminary Unaudited Net Sales Results For August 2009 56732 3NBTY To Web Cast Presentation at CL King Best Ideas Conference 3B Announces Preliminary Unaudited Net Sales Results For August 2009 56732 4
...ls that multiply and migrate in the, embryo to giv... a finding, that suggests that these cells might ...n., Oct. 3 Investigators at St.,Jude Children,s R...he,origin of the mammalian lymphatic vasculature -...to various essential housekeeping functions in the...
...maceuticals, Inc. (Nasdaq: TPPH ) announced today...i-center study of TPI 287 in patients with,advance...ial exploring the,activity of TPI 287 in various t...this year in advanced hormone refractory prostate ...oved for pancreatic cancer and,effective treatment...
Other Medicine Technology:St. Jude Settles Century-Old Debate on Origin of Mammalian Network of Lymphatic Vessels 2Tapestry Initiates Phase 2 Trial of TPI 287 for the Treatment of Advanced Pancreatic Cancer 2Tapestry Initiates Phase 2 Trial of TPI 287 for the Treatment of Advanced Pancreatic Cancer 3Tapestry Initiates Phase 2 Trial of TPI 287 for the Treatment of Advanced Pancreatic Cancer 4Tapestry Initiates Phase 2 Trial of TPI 287 for the Treatment of Advanced Pancreatic Cancer 5
CRP FULL RANGE (0.1-160 mg/l)
Uric Acid (UA)
Apolipoprotein B (undiluted sample) Liquid
Urea (Kinetic) 3 minute read
Medicine Products: